News & Announcements

August 2017

Fighting white supremacy and advancing equity and justice

Last weekend's events in Charlottesville horrified us beyond words. We are heartbroken that lives were lost and devastated by the violence inflicted on the community of Charlottesville, the effects of which reverberated far beyond. We condemn these actions and the white supremacists who committed...
August 2017

Updated report: States with most abortion restrictions have the fewest supportive policies for women, children

States with the highest number of abortion restrictions tend to have the worst women and children’s health outcomes and fewest supportive policies that would actually advance the health and well-being of families—according to an updated report released by the Center for Reproductive...
June 2017

Washington Post op-ed: Pharmacy access today, and OTC access on the horizon

The Washington Post published an op-ed by Ibis's Vice President for Development and Public Affairs Britt Wahlin which celebrates the new law in Maryland that will soon allow pharmacists to prescribe contraception, but reminds readers that an over-the-counter (OTC) birth control pill is on the...
May 2017

Mmoho campaign featured on popular South African TV show

On May 4, Communications and Outreach/Research Coordinator Bongeka Cutshwa and Research Coordinator Maureen Mtimkulu appeared on SABC 3, a South African national television station, to speak about our work to address the sexual and reproductive health needs of young people and the mmoho campaign...
April 2017

Ibis responds to elimination of US UNFPA funding

We at Ibis are deeply disappointed by the Trump administration’s decision to cut all funding for the United Nations Population Fund (UNFPA). UNFPA provides life-saving and critical services like family planning, midwife training, and safe childbirth; the organization also works to put an end...
March 2017

Removing unnecessary barriers to medication abortion

Ibis President Kelly Blanchard joined a group of experts from several disciplines to release a commentary published last week in the New England Journal of Medicine highlighting the harms caused by overregulation of mifepristone in the United States. The FDA regulation mechanism known as REMS (Risk...

Share This